Somastat Injection
Somatostatin
0.25mg
Sun Pharmaceutical Industries Ltd.
| Pack size | |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price |
Available as:
Indications
Somastat Injection is used for:
GI haemorrhage
Adult Dose
Intravenous
Gastrointestinal haemorrhage
Adult: Initially, 250 mcg as a bolus inj over 3-5 min, followed by a continuous infusion of 3.5 mcg/kg/hr until bleeding has ceased. May continue for a further 48-72 hr to prevent recurrent bleeding.
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Monitor blood glucose levels. May inhibit intestinal absorption thus concomitant parenteral nutrition may be recommended.
Pregnancy-Lactation
Interactions
Lengthens the time of hexobarbital-induced sleep & potentiates the action of pentetrazol.
Adverse Effects
Side effects of Somatostatin :
Rapid infusion may lead to abdominal discomfort, nausea, flushing, bradycardia.
Mechanism of Action
Somatostatin is a polypetide obtained synthetically or from the hypothalamus. It acts by inhibiting the release of growth hormone from the anterior pituitary. It also inhibits the release of thyrotrophin and corticotropin from the pituitary, glucagon and insulin from the pancreas. It also regulates duodenal and gastric secretions. It may also play a role in pain perception.
Note
Somastat 0.25mg Injection manufactured by Sun Pharmaceutical Industries Ltd.. Its generic name is Somatostatin. Somastat is availble in Nepal.
Farmaco Nepal drug index information on Somastat Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.